| Autor: |
Osama O. Zaidat, Hormozd Bozorgchami, Marc Ribó, Jeffrey L. Saver, Heinrich P. Mattle, René Chapot, Ana Paula Narata, Olivier Francois, Ashutosh P. Jadhav, Jonathan A. Grossberg, Christian H. Riedel, Alejandro Tomasello, Wayne M. Clark, Hannes Nordmeyer, Eugene Lin, Raul G. Nogueira, Albert J. Yoo, Tudor G. Jovin, Adnan H. Siddiqui, Thierry Bernard, Mairsíl Claffey, Tommy Andersson, M. Ribo, S. Hetts, W. Hacke, Brijesh Mehta, L. Hacein-Bey, A. Kim, A. Abou-Chebl, P. Shabe, J. Dix, J. Gurian, W.E. Zink, G. Dabus, N. O’Leary, A. Reilly, K. Lee, J. Foley, M. Dolan, E. Hartley, T. Clark, K. Nadeau, J. Shama, L. Hull, B. Brown, R. Priest, G. Nesbit, M. Horikawa, D. Hoak, B. Petersen, Noah Beadell, Kory Herrick, C. White, M. Stacey, S. Ford, J. Liu, M. Ribó, E. Sanjuan, M. Sanchis, C. Molina, D. Rodríguez-Luna, S. Boned Riera, J. Pagola, M. Rubiera, J. Juega, N. Rodríguez, N. Muller, M. Stauder, P. Stracke, M. Heddier, V. Charron, A. Decock, D. Herbreteau, R. Bibi, A.S. De Sloovere, I. Doutreloigne, D. Pieters, T. Dewaele, P. Bourgeois, F. Vanhee, P. Vanderdouckt, E. Vancaster, L. Baxendell, V. Gilchrist, Y. Cannon, C. Graves, K. Armbruster, T. Jovin, B. Jankowitz, A. Ducruet, A. Aghaebrahim, C. Kenmuir, H. Shoirah, B. Molyneaux, P. Tadi, G. Walker, M. Starr, S. Doppelheuer, K. Schindler, L. Craft, M. Schultz, H. Perez, J. Park, A. Hall, A. Mitchell, L. Webb, D. Haussen, M. Frankel, N. Bianchi, S. Belagaje, N. Mahdi, S. Lahoti, A. Katema, M. Winningham, A. Anderson, D.A. Tilley, T. Steinhauser, D. Scott, A. Thacker, V. Calderon, E. Lin, S. Becke, S. Krieter, O. Jansen, F. Wodarg, N. Larsen, A. Binder, C. Wiesen, M. Hartney, L. Bookhagan, H. Ross, J. Gay, K. Snyder, E. Levy, J. Davies, A. Sonig, L. Rangel-Castilla, A. Mowla, H. Shakir, V. Fennell, G. Atwal, S. Natarajan, J. Beecher, J. Thornton, A. Cullen, P. Brennan, A. O’Hare, H. Asadi, R. Budzik, M. Taylor, M. Jennings, F. Laube, J. Jackson, R. Gatrell, L. Reebel, A. Albon, J. Gerniak, K. Groezinger, M. Lauf, N. Voraco, P. Pema, T. Davis, W. Hicks, J. Mejilla, M. Teleb, P. Sunenshine, E. Russo, R. Flynn, J. Twyford, A. Ver Hage, E. Smith, L. Apolinar, S. Blythe, J. Maxan, J. Carter, T. Taschner, U. Bergmann, S. Meckel, S. Elsheik, H. Urbach, C. Maurer, K. Egger, W.D. Niesen, B.W. Baxter, A. Knox, B. Hazelwood, S. Quarfordt, J. Calvert, H. Hawk, R. Malek, A. Padidar, U. Tolley, A. Gutierrez, P. Mordasini, T. Seip, R. Balasubramaniam, J. Gralla, U. Fischer, F. Zibold, E. Piechowiak, R. DeLeacy, R. Apruzzeses, C. Alfonso, J. Haslett, J. Fifi, J. Mocco, S. Starkman, J. Guzy, N. Grunberg, V. Szeder, S. Tateshima, G. Duckwiler, M. Nour, D. Liebeskind, X. Tang, J. Hinman, A. Tipirneni, D. Yavagal, L. Guada, K. Bates, S. Balladeras, S.K. Bokka, S. Suir, J. Caplan, P. Kandewall, E. Peterson, R.M. Starke, A. Puri, M. Hawk, C. Brooks, J. L’Heurex, K. Ty, D. Rex, F. Massari, A. Wakhloo, D. Lozano, K.D. Rodrigua, L. Pierot, M. Fabienne, S. Sebastien, M.G. Emmoinoli |
| Rok vydání: |
2018 |
| Předmět: |
|
| Popis: |
Background and Purpose— EmboTrap is a novel stent retriever designed to achieve rapid and substantial flow restoration in acute ischemic stroke secondary to large-vessel occlusions. Here, we evaluated EmboTrap’s safety and efficacy compared with established stent retrievers. Methods— ARISE II (Analysis of Revascularization in Ischemic Stroke With EmboTrap) was a single-arm, prospective, multicenter study, comparing the EmboTrap device to a composite performance goal criterion derived using a Bayesian meta-analysis from the pivotal SWIFT (Solitaire device) and TREVO 2 (Trevo device) trials. Patients at 11 US and 8 European sites were eligible for inclusion if they had large-vessel occlusions and moderate-to-severe neurological deficits within 8 hours of symptom onset. The primary efficacy end point was achievement of modified Thrombolysis in Cerebral Ischemia (mTICI) reperfusion scores of ≥2b within 3 EmboTrap passes as adjudicated by the core laboratory. The primary safety end point was a composite of symptomatic intracerebral hemorrhage and serious adverse device effects. Secondary end points included functional independence (modified Rankin Scale, 0–2) and all-cause mortality at 90 days. Results— Between October 2015 and February 2017, 227 patients were enrolled and treated with the EmboTrap device. The primary efficacy end point (mTICI ≥2b within 3 passes) was achieved in 80.2% (95% confidence interval, 74%–85% versus 56% performance goal criterion; P value, Conclusions— The EmboTrap stent-retriever mechanical thrombectomy device demonstrated high rates of substantial reperfusion and functional independence in patients with acute ischemic stroke secondary to large-vessel occlusions. Clinical Trial Registration— URL: http://www.clinicaltrials.gov . Unique identifier: NCT02488915. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
